Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | pteridine reductase 1 | 0.0218 | 0.0279 | 0.0442 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0079 | 0.007 | 0.0048 |
Chlamydia trachomatis | dihydrofolate reductase | 0.6709 | 1 | 0.5 |
Brugia malayi | Amyloid A4 extracellular domain containing protein | 0.0319 | 0.043 | 0.0408 |
Brugia malayi | thymidylate synthase | 0.1106 | 0.1609 | 0.159 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0085 |
Schistosoma mansoni | dihydrofolate reductase | 0.6709 | 1 | 1 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0109 | 0.0115 | 0.0095 |
Brugia malayi | hypothetical protein | 0.0526 | 0.074 | 0.0719 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.1106 | 0.1609 | 0.159 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.007 | 0.0048 |
Echinococcus granulosus | thymidylate synthase | 0.1106 | 0.1609 | 0.159 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0101 | 0.0078 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0085 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.4242 | 0.6305 | 1 |
Echinococcus multilocularis | solute carrier family 2, facilitated glucose | 0.0104 | 0.0107 | 0.0087 |
Loa Loa (eye worm) | thymidylate synthase | 0.1106 | 0.1609 | 0.159 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0147 | 0.0172 | 0.0153 |
Leishmania major | pteridine reductase 1 | 0.0221 | 0.0283 | 0.0449 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0526 | 0.074 | 0.1174 |
Echinococcus multilocularis | dihydrofolate reductase | 0.6709 | 1 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.4242 | 0.6305 | 1 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0109 | 0.0115 | 0.0092 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0087 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0079 | 0.007 | 0.005 |
Echinococcus granulosus | General substrate transporter | 0.0089 | 0.0085 | 0.0063 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0109 | 0.0115 | 0.0092 |
Loa Loa (eye worm) | sugar transporter | 0.0104 | 0.0107 | 0.0085 |
Echinococcus multilocularis | thymidylate synthase | 0.1106 | 0.1609 | 0.1592 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.6709 | 1 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.6709 | 1 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.6709 | 1 | 1 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0085 |
Schistosoma mansoni | glucose transport protein | 0.0104 | 0.0107 | 0.0085 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0147 | 0.0172 | 0.015 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.007 | 0.0048 |
Schistosoma mansoni | tyrosine kinase | 0.0147 | 0.0172 | 0.015 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.4242 | 0.6305 | 1 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0087 |
Schistosoma mansoni | glucose transport protein | 0.0104 | 0.0107 | 0.0085 |
Echinococcus granulosus | dihydrofolate reductase | 0.6709 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 0.0328 | 0.0307 |
Schistosoma mansoni | tyrosine kinase | 0.0078 | 0.0069 | 0.0047 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.4242 | 0.6305 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0526 | 0.074 | 1 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0085 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0104 | 0.0107 | 0.1445 |
Schistosoma mansoni | glucose transport protein | 0.0104 | 0.0107 | 0.0085 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0079 | 0.007 | 0.0048 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0147 | 0.0172 | 0.015 |
Loa Loa (eye worm) | hypothetical protein | 0.0135 | 0.0154 | 0.0132 |
Echinococcus multilocularis | insulin receptor | 0.0047 | 0.0022 | 0.0002 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.4242 | 0.6305 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0078 | 0.0069 | 0.0047 |
Brugia malayi | Sugar transporter family protein | 0.0104 | 0.0107 | 0.0085 |
Schistosoma mansoni | tyrosine kinase | 0.0078 | 0.0069 | 0.0047 |
Loa Loa (eye worm) | nuclear hormone receptor | 0.0098 | 0.0099 | 0.0077 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.4242 | 0.6305 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.0107 | 0.0085 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0047 | 0.0022 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0053 | 0.0031 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0104 | 0.0107 | 0.0087 |
Onchocerca volvulus | 0.1106 | 0.1609 | 0.5 | |
Echinococcus multilocularis | General substrate transporter | 0.0089 | 0.0085 | 0.0065 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.1106 | 0.1609 | 0.0938 |
Brugia malayi | Dihydrofolate reductase | 0.6709 | 1 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.6709 | 1 | 1 |
Schistosoma mansoni | alzheimer's disease beta-amyloid related | 0.0116 | 0.0126 | 0.0104 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0147 | 0.0172 | 0.015 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.08 | 0.115 | 0.1133 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.